[Novel therapeutic strategy for diabetic nephropathy].
Isono
Motohide
M
Department of Medicine, Shiga University of Medical Science.
Haneda
Masakazu
M
D000818:Animals; D004268:DNA-Binding Proteins / Q000502:physiology; D003864:Depression, Chemical; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000209:etiology; D005109:Extracellular Matrix / Q000378:metabolism; D006801:Humans; D009842:Oligopeptides / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D010766:Phosphorylation / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D051785:Smad Proteins; D015534:Trans-Activators / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors / Q000502:physiology
D004268:DNA-Binding Proteins; D009842:Oligopeptides; D051785:Smad Proteins; D015534:Trans-Activators; D016212:Transforming Growth Factor beta; C058504:goralatide